Wade M. Aubry, M.D.

Former Senior Vice President & Chief Medical Officer, Blue Shield of California

Dr. Aubry is a health policy researcher, consultant, and clinician based in San Francisco with extensive experience in health care technology assessment and coverage decision making. He is Associate Clinical Professor of Medicine and Core Faculty at the Philip R. Lee Institute for Health Policy Studies at UCSF, Senior Clinical and Policy Advisor for the Center for Medical Technology Policy (CMTP), and Senior Medical Advisor for the Blue Shield of California Foundation’s California Technology Assessment Forum (CTAF). He is also a practicing endocrinologist at Saint Francis Memorial Hospital in San Francisco, where he chairs its Institutional Review Board and has served as Chief of Staff. Previously, he was a Senior Advisor at the Health Technology Center (HealthTech), Vice President of the Lewin Group, Senior Vice President and Chief Medical Officer for Blue Shield of California, Medicare Part B Medical Director for Northern California, and National Medical Consultant for the Blue Cross Blue Shield Association (BCBSA), where he chaired its Technology Evaluation Center’s national Medical Advisory Panel for several years.

Dr. Aubry received his B.S. degree Phi Beta Kappa from Stanford University, his M.D. degree from the UCLA School of Medicine, and his postgraduate training at Cedars-Sinai Medical Center. He has served on numerous national health care advisory committees, including NIH committees on clinical trials and managed care, various IOM committees and roundtables, the AHRQ Effective Health Care Program Stakeholder Group, the American College of Radiology Imaging Network (ACRIN) External Advisory Panel, the National Committee for Quality Assurance (NCQA) Geriatrics Measurement Advisory Panel, and two terms on the CMS Medicare Evidence Development & Coverage Advisory Committee. Currently, he is a member of the UCSF Healthcare Technology Assessment Program (HTAP) Committee and the UCSF Effectiveness Center for the California Health Benefits Review Program (CHBRP), which produces evidence reports on proposed health insurance mandates in California. He teaches on medical technology and health policy at UCSF, UC Berkeley, and UCLA, has lectured internationally, and has published numerous articles on medical technology and managed care. He is also co-author of a comprehensive case study on bone marrow transplants for breast cancer entitled False Hope: Bone Marrow Transplantation for Breast Cancer, which was published by Oxford University Press in 2007.

Education

B.S., Phi Beta Kappa, Stanford University

M.D., UCLA School of Medicine

Expertise